Leading Article
Acute kidney injury (AKI) in paediatric patients is characterized clinically by rapid loss of glomerular filtration rate (GFR) resulting in failure to excrete end products of nitrogen metabolism and to mantain fluid volume and electrolyte and acid base homeostasis. 1, 2 The incidence of AKI is rising in children both in developed and developing country with significantly increased mortality and morbidity in paediatric population as well as in paediatric intensive care unit (ICU). 3, 4 In a few studies, it has been observed that incidence of AKI varies from 30-50% in children undergoing cardiac surgery and even may go upto 82% in critically ill children with multiple organ failure. 5 Till now due to lack of consensus on the definition of AKI, the incidence of AKI in the paediatric group of population is yet to be remain unknown in the developing country. But in the industrilized countries the incidence of AKI in hospitalized children is rising and the etiology of peadiatric AKI is dramatically changing from isolated acute renal disease to multiple organ failure. So to make a consensus on the definition of AKI in 2004 the acute dialysis quality initiative (ADQI) proposed RIFLE criteria for defining AKI based on risk, injury, failure, loss of kidney function and end stage renal disease (RIFLE). Three years later acute kidney injury network (AKIN) modified RIFLE criteria for paediatric patient (pRIFLE) based on estimated creatinine clearance (eCCl) and urine output considering body weight of the patient. 6 In clinical practice, traditionaly serum creatinine (Cr), serum creatinine clearance (CCr) and urine output are used as the primary test to diagnose paediatric acute kidney injury 5 . Serum creatinine takes 24-48 hours to rise after initial renal insult which limits its early diagnostic value and potential for early intervention. In spite of this loophole there are also some limitations of serum creatinine as a diagnostic tool for AKI which are as follows: a) Serum creatinine do not reflect degree of renal injury but only renal function.
b) Serum creatinine is affected by other non-renal factors like muscle mass, hydration status, sex, age, medication and bilirubin level. 7 c) The value of serum creatinine can not be used to distinguish from pre-renal cause of AKI to intrinsic renal failure or obstructive uropathy. 5 d) Small increase in serum creatinine may be mistaken as fluctuation remaining within normal limits. Now a days, it is accepted that the serum creatinine is an insensitive and delayed measure of decreased kidney function following AKI. [9] [10] [11] [12] [13] [14] [15] Multiple studies have focused on the developement of the selective and specific biomarker of AKI. 9 Most of the biomarkers are protein bound and indications of structural renal damaged rather than of decreased kidney function. 5 Moreover an ideal AKI biomarker should be acurate, reliable, easy to mesure with a standard assay, noninvassive, representable, sensitive and specific with defined cut off values. 5 Urine represent an ideal body fluid for AKI biomarker assessment as it can be obtained noninvassively and repeatedly. from a sponteneously voided urine sample or from an indwelling bladder catheter 5, 8 . Multiple studies has focused on the development of sensitive and specific different biomarkers of AKI which are nutrophil gelatinase associated lipocalin (NGAL), cystatin C, kidney injury molecule-1 (KIM-1), b-2 microglobulin (b 2 M), Interleukin 18 (IL-18) and urinary liver type fatty acid binding protein (L-FABP) show promise in both diagnostic and prognostic utility for AKI from various causes. In a nut shell, the use of newly discoverd biomarkers for early diagnosis and intervention of AKI patients are described bellow:
Modified RIFLE criteria for paediatric patients (pRIFLE)

RIFLE
Nutrophil Gelatinase Associated Lipocalin (NGAL):
Nutrophil gelatinase associated lipoprotein (NGAL) is a 25 kDa protein bound to gelatinase from neutrophil 16 . NGAL is found to be one of the most rapidly induced protein in the kidney folling experimental AKI and NGAL appeared in the urine before other biomarker. 10, 11 The level of NGAL increased in plasma and urine hours of cardiac surgery in those who developed AKI compared to 2-4 days for increase in serum creatinine to occur. 11 NGAL is also shown to be an early predictor of contrast induced nephropathy in children. 12 But there is also some non-specificity of NGAL as biomarker of AKI because some other factors may influence the NGAL e.g NGAL acitvity is inhibited by endogeneous urea, nephrotoxins and heavy metals. 17 Eleveted level of NGAL may be found in Juvenile rheumatoid arthritis, impaired glucose tolerance and hypothyroidism. 17 So this factors make the NGAL not specific to be used as a biomarker in AKI.
Interleukin 18 (IL-18):
It is a proinflammatory citokines is produced at the proximal tubular cells and it is identified as a very early biomarker of AKI in kidney transplant patients, acute respiratory distress syndrome and after cardiopulmonary bypass surgery. 18 A major drawback limits the routine use of biomarker is their low individual sensitivity and specificity not exceding 70-75% for detection of early kidney damage. 19 From different studies it was observed that IL-18 performed moderately well for detecting AKI in four different population, adults who underwent cardiac surgery, children who are critically ill, adults with acute lung injury and adults who received kidney transplantation.
Kidney injury molecule-1 (KIM-1):
It is a trnasmembrane protein produced by the proximal tubule following ischemic or toxin induced AKI. This urinary biomarker is investigated in patients undergoing cardiopulmonary bypass 20 . In this situation it is proved more specific than NGAL but in some situation NGAL is more sensitive than KIM-1 in ishemic and nephrotoxic induced AKI. 17
Cystatin C:
It is a protease inhibitor is relesed into the blood, filtered in the glomerulus and completely reabsorbed in the proximal tubule. In cardiac surgry patient a 50% increased in cystatine C could predict AKI 48 hour before changes in serum creatinine or creatinine clearance suggested renal dysfunction 7 . However NGAL is an earlier biomarker than cystatin C. 17 b 2 microglobulin: b 2 microglobulin are low molecular weight proteins freely filtered by the glomerulus. 17 b 2 microglobulin concentration are less dependent on extra renal factors like creatinine. 20 In a cross sectional analysis, HerronMorin and co-workers showed that cystatin C and b 2 M was found to be largely superior to a creatinine clearance cutoff <80 ml/min/1.73 m 2 for detecting decreased glomerular rate in critically ill children. 17
Urinary liver type fatty acid binding protein (L-FABP):
L-FABP is a small cytoplasmic protein has been shown to be a sensitive and early predictor of AKI in paediatric patients undergoing cardiac surgery. 15 In a prospective case control study by Portilua et al demostrating for the first time that urinary excretion of L-FABP in paediatric patients undergoing cardiac surgery is significantly increased within the first hours whereas serum creatinine rises after 24-72 hours after cardiac surgery. 18, 20 Limitations of Biomarkers: A major drawback limiting the routine use of biomarkers is their low individual selectivity and sensitivity not exceding 70-75% for detecting early kidney damage. 20 One possible solutions might be the creation of a kit incorporating various biomarkers to allow quick and acurate diagnosis of AKI. 21, 22 In a recent study, NGAL and serum creatinine derived GFR or both predicted development of severe AKI. 23 On the other hand in the presence of normal serum creatinin values, NGAL alone may remain predictive for AKI. At present the paediatric nephrologist are in an unprecendented level to deal with the newer biomarker such as NGAL, KIM-1, IL-18 and LFABP due to their low sensitivity and specificity individualy. It is highly likely that these novel biomarkers alone or in-combination will be introduced over the next few years for early diagnosis and intervention of paediatric AKI patients. 24 
